HOME | DEUTSCH | CONTACT | SITEMAP | IMPRINT
ABOUT | NEWS | PRODUCTS | TECHNOLOGY | INVESTOR RELATIONS | CAREER
PRODUCT PIPELINE
CANCER THERAPIES
CANCER THERAPY WITH dSLIM
CELL-BASED GENE THERAPY
ANTI-INFECTIVES
Cell-based gene therapy - Mechanism of action
back
MOLOGEN®, MIDGE® and dSLIM® are registered trademarks of MOLOGEN AG
More information about our technologies
MIDGE
MIDGE-Th1
dSLIM
Joerg Petrass
Dr. Matthias Schroff
Arlett Killat
MOLOGEN AG publishes results for the first nine months of 2008 and gives an overview of R&D activities
more
MOLOGEN AG receives patent for cell based gene therapy
TOP OF PAGE | HOME | IMPRINT | DISCLAIMER